chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: HEPAB, HEPAB
Symptoms: Inappropriate schedule of product administration, Incomplete course of vaccination
Clinical narrative: patient received their second dose of Twinrix a year ago and wished to know if the third dose could be administered; patient received first dose on 02-JUL-2022 and second dose on 10-AUG-2022; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 65-year-old female patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (received 1st dose of Twinrix on 02 July 2023).   On 10-AUG-2022, the patient received the 2nd dose of Twinrix. On an unknown date, the patient did not receive the 3rd dose of Twinrix. On 10-AUG-2022, an unknown time after receiving Twinrix and not applicable after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: patient received first dose on 02-JUL-2022 and second dose on 10-AUG-2022). On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: patient received their second dose of Twinrix a year ago and wished to know if the third dose could be administered). The outcome of the drug dose administration interval too long and incomplete course of vaccination were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-AUG-2023 The [pharmacist stated that patient received 2 doses of Twinrix a year ago in 2022. Patient wished to know that if she can receive her 3rd dose or the series needed to be restarted. The vaccine administration facility was the same as primary reporter. The patient received 2nd dose of Twinrix , later than the recommended interval, which led to lengthening of vaccination schedule. Till the time of reporting, the patient did not receive 3rd  dose of Twinrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Sex: F
Vaccine: DTAPIPV
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: inappropriate schedule of vaccine; They may be giving Kinrix as the next dose of Dtap/IPV; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate schedule of vaccine administered in a 5-year-old female patient who received DTPa-IPV (Kinrix) for prophylaxis.   Concomitant products included DIPHTHERIA VACCINE TOXOID + PERTUSSIS VACCINE ACELLULAR + TETANUS VACCINE TOXOID (DTAP), POLIOMYELITIS VACCINE INACTIVATED (IPV), HEPATITIS B VACCINE and MMR (MEASLES/MUMPS/RUBELLA).   On an unknown date, the patient did not receive Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate schedule of vaccine administered (Verbatim: inappropriate schedule of vaccine) and circumstance or information capable of leading to medication error (Verbatim: They may be giving Kinrix as the next dose of Dtap/IPV). The outcome of the inappropriate schedule of vaccine administered and circumstance or information capable of leading to medication error were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-AUG-2023 The clinic reported they had a 5 year old patient who had never received any vaccines. They might be giving Kinrix as the next dose of Dtap/IPV as the first doses she got were two separate vaccines, and they would like to combine them, which led to inappropriate schedule of vaccine administered and circumstance or information capable of leading to medication error. vaccine specialist stated it might be as the patient was off schedule already the patient got a dose of Dtap, IPV, Hep-B and MMR, all separately today (reporting day) at their clinic, none were GSK vaccines. The vaccine administration facility was the same as primary reporter for non GSK products. The reporter consented to follow up.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Breakthrough COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID vaccine breakthrough case. Moderna 2/25/21 010A21A, 3/25/21 047A21A, 8/14/21 052E21A, 3/3/22 027L21A and Moderna bivalents 12/6/22 043H22A and 8/3/23 AS7645B.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 42.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Late in the evening on day of vaccination,  patient's (L) arm began to swell, become red and warm to touch, and was painful.  She used ice, Tylenol, and Aleve.  Came to the office the morning of 08/18/23 for us to see her arm.  Dr. examined her arm and instructed her to continue to use ice, Tylenol, Aleve, and Benadryl as needed.  Also instructed her to keep her arm elevated.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Eye swelling, Urticaria
Clinical narrative: She began having swelling around her eyes on 08/05/2023 into 08/06/2023, gave Bendryl but that didn't help. Started having hives on 08/07/2023. Grandmother called clinic on 08/08/2023 to report symptoms. Recommended for her to call childs PCP or go to urgent care or ER today. Attempted to call grandmother for an update on 08/17/2023 and left voicemail.
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, Pain, Vaccine positive rechallenge
Clinical narrative: body aches the next day; tiredness; This non-serious case was reported by a consumer via call center representative and described the occurrence of general body pain in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of fatigue (1st dose received on 23rd March 2021, refer case US2023109506).   On 18-JUN-2021, the patient received the 2nd dose of Shingrix. On 19-JUN-2021, 1 days after receiving Shingrix, the patient experienced general body pain (Verbatim: body aches the next day) and tiredness (Verbatim: tiredness). Rechallenge with Shingrix was positive. The outcome of the general body pain and tiredness were resolved (duration 24 hrs).   It was unknown if the reporter considered the general body pain and tiredness to be related to Shingrix.     It was unknown if the company considered the general body pain and tiredness to be related to Shingrix.   Linked case(s) involving the same patient:  US2023109506   Additional Information: GSK Receipt date: 11-AUG-2023 The reporter was the wife of the patient. After the patient received the second dose, the patient experienced the same events, tiredness and body aches the next day which lasted for 24 hours. The reporter consented to follow up.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA ANGINA, UNSPECIFIED
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Facial paresis, Pulmonary embolism, Symptom recurrence
Clinical narrative: ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY ACUTE PULMONARY EMBOLISM RIGHT FACIAL MUSCLE WEAKNESS 1/24/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiogenic shock, Hypersensitivity
Clinical narrative: CARDIOGENIC SHOCK ALLERGIC REACTION, INIT
Age: 18.0
Sex: F
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Adult dose of Hepatitis A given to 18 yr old patient.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Neuropathy peripheral, Symptom recurrence
Clinical narrative: PERIPHERAL NEUROPATHY 2/7/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Hypoxia, Pneumonia
Clinical narrative: hypoxia, PNA, COVID-19 infection
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/16/2022,  12/17/2022,  12/18/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 17.0
Sex: F
Vaccine: TDAP
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: the administration of Boostrix instead of Infanrix to a 17 month old female patient; 17 month old patient recevied Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 17-month-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number B4C44, expiry date 10-NOV-2024) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced wrong vaccine administered (Verbatim: the administration of Boostrix instead of Infanrix to a 17 month old female patient) and inappropriate age at vaccine administration (Verbatim: 17 month old patient recevied Boostrix). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 14-AUG-2023 The reporter stated the administration of Boostrix instead of Infanrix to a 17 month old patient, which led to wrong vaccine administered and inappropriate age at vaccine administration. The healthcare professional asked how to proceed with this patient. The reporter consented to follow up.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Neuropathy peripheral, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY HYPOTENSION 12/3/2021,  3/3/2022,  4/9/2022,  5/9/2022,  6/14/2022,  6/29/2022,  7/5/2022,  7/6/2022,  7/19/2022,  8/25/2022,  9/29/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 50.0
Sex: F
Vaccine: PNC20, TDAP
Symptoms: Arthralgia, Injection site pain, Muscular weakness, Pain
Clinical narrative: Patient contacted provider office to state that she believed her vaccines (TDAP and PCV20) were given too high up in her left upper extremity. She reports that a couple of days after receiving her vaccinations, she began experiencing sharp pain in her joint of left upper extremity with certain movements and with holding items. Patient contacted today, 8-18-2023 and she reported improvement with symptoms. She states that the administration site is tender when touched, but otherwise her arm feels better this week.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE HYPOXIA 3/12/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: HYPOXIA 2/21/2023 &  1/22/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 1.25
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Expired product administered
Clinical narrative: Patient was given an expired ActHib by one of our Medical Assistants.  Vaccination expired on 8/11/2023 and was administered on 8/16/2023.  This was not discovered until injection was being documented/entered into system.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Age: 0.33
Sex: F
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No signs or symptoms noticed at time of administration. There was no reaction to the given vaccines.
Age: 18.0
Sex: F
Vaccine: HEP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse effects or reactions. Pt received adult instead of pediatric dose.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Herpes simplex test negative, Mucosal ulceration, Oedema genital, Vulvovaginal injury
Clinical narrative: Patient experienced severe labial swelling resulting in cracking and ulceration of the mucosal layer after her second booster of the vaccine.  She has since experienced similar swelling as she has contracted COVID on 2 occasions.  Neither episode that occurred with natural infection was as severe as the episode after vaccination.
Sex: F
Vaccine: MNQ
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: patient received a Menveo dose that was reconstituted using sterile water; patient received a Menveo dose that was reconstituted using sterile water; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 12-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA748A, expiry date 30-NOV-2023) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: patient received a Menveo dose that was reconstituted using sterile water) and inappropriate dose of vaccine administered (Verbatim: patient received a Menveo dose that was reconstituted using sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: Receipt date: 14-Aug-2023 A pharmacist asked for guidance on this situation. The reporter did not consent to follow-up. The patient received a dose of Menveo that was reconstituted using sterile water instead of the supplied meningococcal CYW-135 (MenCYW 135) liquid conjugate vaccine component, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 6.0
Sex: F
Vaccine: TDAP
Symptoms: Wrong product administered
Clinical narrative: Six year old child was inadvertently given a dose of Tdap.  No immediate reactions.  Father instructed to take the child to the ER and contact us following the ER visit.  Follow up calls to client for report of any possible adverse reactions.  Parent reports that daughter is "fine" and "ok."  Will follow up on Monday, August 22, 2023 which will be the 7th day.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Ischaemic stroke
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT OF RIGHT FEMORAL VEIN
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 1.17
Sex: F
Vaccine: HEPA, MMR
Symptoms: Ear swelling, Eye swelling, Swelling face
Clinical narrative: Patient noted to have severe swelling to face, bilateral eyes, and bilateral ears .
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Muscular weakness
Clinical narrative: Have had muscle weakness on right shoulder and hand since the injection.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Pulmonary embolism, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM 8/12/2022 &  10/8/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: hasn't received a second dose yet; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix  (received first dose in June 2022).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: hasn't received a second dose yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 14-Aug-2023 During the call nurse declined to provide more information. The reporter consented to follow-up via email. Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination.
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA, MMR, PNC13, VARCEL
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt was given the diluent part of the Pentacel vaccine which includes the DTAP and Polio-IPV. The diluent was not mixed with the powder which included the HIB portion of the vaccine.  So the pt did not receive the HIB vaccine on 08/16/2023.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 3/24/2023 ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI 4/26/2023 ACUTE NON ST ELEVATION MI
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Coronary artery disease
Clinical narrative: I21.4 ACUTE NON ST ELEVATION MI 2/8/2023 ACUTE NON ST ELEVATION MI I21.4 ACUTE NON ST ELEVATION MI 2/8/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Age: 53.0
Sex: F
Vaccine: HEP
Symptoms: Product administration error
Clinical narrative: ADMINISTRATION ERROR: NURSE NOTIFIED PROPER CHANNELS AND PT IS RETURNING NEXT WEEK FOR ADULT DOSE.
Age: 50.0
Sex: F
Vaccine: HPV9
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine given to patient over the age of 45
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN
Age: 36.0
Sex: M
Vaccine: VARCEL
Symptoms: Asthenia, Blood test, Chest X-ray, Chest discomfort, Dizziness
Clinical narrative: 08/10/23 Received varicella vaccine - felt run down just finished summer program  08/11/23 symptoms:   shortness of breath, tightening of chest (wakening during the night gasping), instense hot flashes - mostly when eating food, light headed and dizzy, little tighening of throat, numbness in lips. Symptoms worsening over time.   Lightheadedness and weakness most debilitating.    08/15/23 - due to symptoms, took a covid test and it was negative.   08/17/23 went to the ER  after throat was more uncomfortable than it has been.   EKG & CXR done.  Blood work done.  No IV.  No meds administered.  Was advised to contact clinic to report VAERS and also not to get the 2nd dose.  He will need a note from a doctor to excuse him from the 2nd dose of varicella.   Right now, feeling better mentally -odds are symptoms will taper off.   In general, haven't eaten anything today.  Feels light headed/dizzy/weak.  Short of breath (more localized in chest).  Throat - still swollen, red.   08/17/23 - seen by MD who recommended that he not receive 2nd dose of varicella and to report the adverse reactions.
Age: 36.0
Sex: M
Vaccine: VARCEL
Symptoms: Dyspnoea, Electrocardiogram, Fatigue, Hot flush, Hypoaesthesia oral
Clinical narrative: 08/10/23 Received varicella vaccine - felt run down just finished summer program  08/11/23 symptoms:   shortness of breath, tightening of chest (wakening during the night gasping), instense hot flashes - mostly when eating food, light headed and dizzy, little tighening of throat, numbness in lips. Symptoms worsening over time.   Lightheadedness and weakness most debilitating.    08/15/23 - due to symptoms, took a covid test and it was negative.   08/17/23 went to the ER  after throat was more uncomfortable than it has been.   EKG & CXR done.  Blood work done.  No IV.  No meds administered.  Was advised to contact clinic to report VAERS and also not to get the 2nd dose.  He will need a note from a doctor to excuse him from the 2nd dose of varicella.   Right now, feeling better mentally -odds are symptoms will taper off.   In general, haven't eaten anything today.  Feels light headed/dizzy/weak.  Short of breath (more localized in chest).  Throat - still swollen, red.   08/17/23 - seen by MD who recommended that he not receive 2nd dose of varicella and to report the adverse reactions.
Age: 36.0
Sex: M
Vaccine: VARCEL
Symptoms: Laboratory test, Oropharyngeal discomfort, Pharyngeal erythema, Pharyngeal swelling, SARS-CoV-2 test negative
Clinical narrative: 08/10/23 Received varicella vaccine - felt run down just finished summer program  08/11/23 symptoms:   shortness of breath, tightening of chest (wakening during the night gasping), instense hot flashes - mostly when eating food, light headed and dizzy, little tighening of throat, numbness in lips. Symptoms worsening over time.   Lightheadedness and weakness most debilitating.    08/15/23 - due to symptoms, took a covid test and it was negative.   08/17/23 went to the ER  after throat was more uncomfortable than it has been.   EKG & CXR done.  Blood work done.  No IV.  No meds administered.  Was advised to contact clinic to report VAERS and also not to get the 2nd dose.  He will need a note from a doctor to excuse him from the 2nd dose of varicella.   Right now, feeling better mentally -odds are symptoms will taper off.   In general, haven't eaten anything today.  Feels light headed/dizzy/weak.  Short of breath (more localized in chest).  Throat - still swollen, red.   08/17/23 - seen by MD who recommended that he not receive 2nd dose of varicella and to report the adverse reactions.
Age: 36.0
Sex: M
Vaccine: VARCEL
Symptoms: Sleep disorder, Throat tightness
Clinical narrative: 08/10/23 Received varicella vaccine - felt run down just finished summer program  08/11/23 symptoms:   shortness of breath, tightening of chest (wakening during the night gasping), instense hot flashes - mostly when eating food, light headed and dizzy, little tighening of throat, numbness in lips. Symptoms worsening over time.   Lightheadedness and weakness most debilitating.    08/15/23 - due to symptoms, took a covid test and it was negative.   08/17/23 went to the ER  after throat was more uncomfortable than it has been.   EKG & CXR done.  Blood work done.  No IV.  No meds administered.  Was advised to contact clinic to report VAERS and also not to get the 2nd dose.  He will need a note from a doctor to excuse him from the 2nd dose of varicella.   Right now, feeling better mentally -odds are symptoms will taper off.   In general, haven't eaten anything today.  Feels light headed/dizzy/weak.  Short of breath (more localized in chest).  Throat - still swollen, red.   08/17/23 - seen by MD who recommended that he not receive 2nd dose of varicella and to report the adverse reactions.
Sex: U
Vaccine: HEPAB
Symptoms: Incomplete course of vaccination
Clinical narrative: second dose has not been administered yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received HAB (Twinrix) for prophylaxis.   Concomitant products included HEPATITIS A VACCINE + HEPATITIS B VACCINE (TWINRIX).   On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: second dose has not been administered yet). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 15-Aug-2023 The pharmacist called to inquired that how to proceed with Twinrix rapid dosing schedule. The patient was on the accelerated schedule and was at 11 days for a second dose. The reporter mentioned that this patient was leaving out of the country and wanted guidance of series schedule. The reporter declined to provide any patient details. The reporter did not consent to follow-up. Till the time of reporting, the patient did not receive the second dose of Twinrix, which led to incomplete course of vaccination.
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Exposure during pregnancy, Product storage error
Clinical narrative: Immunization was given out of a vial that was opened the day before.  Dose given on 8/17/23.  Vial opened on 8/16/2023
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Facial paresis, Hypertension, Migraine, Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA 4/14/2023 HTN (HYPERTENSION) RIGHT FACIAL MUSCLE WEAKNESS 4/10/2023 HTN (HYPERTENSION) TRANSIENT CEREBRAL ISCHEMIA 4/14/2023 MIGRAINE RIGHT FACIAL MUSCLE WEAKNESS 4/10/2023 MIGRAINE
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Angina unstable
Clinical narrative: UNSTABLE ANGINA
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Hypomagnesaemia
Clinical narrative: T78.40XS ALLERGIC DISORDER, SEQUELA 4/20/2023 HYPOMAGNESEMIA
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Altered visual depth perception, Diplopia, Eyelid ptosis, Laboratory test
Clinical narrative: Drooping eyelids, double vision loss of depth perception
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Pain, Pain in extremity
Clinical narrative: She got her vaccine, her arm was hurting but that was normal with every vaccine.  DIdn't have any symptoms other than that until this morning.  She has body aches, and temperature of 100.9 and a headache.  He has taken Ibuprofen for her symptoms, and she ordered a COVID test online and is waiting for that one to come.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Acute coronary syndrome, Acute myocardial infarction
Clinical narrative: ACUTE ST ELEVATION MI, RIGHT CORONARY ARTERY ACUTE CORONARY SYNDROME, UNSPECIFIED
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic obstructive pulmonary disease, Condition aggravated, Respiratory failure
Clinical narrative: ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/15/2023 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 4/15/2023 ACUTE EXACERBATION OF COPD
Age: 0.5
Sex: F
Vaccine: DTAP
Symptoms: Extra dose administered, Irritability
Clinical narrative: Patient was given a Daptacel (Dtap/Hib/Polio) vaccine in addition to a Vaxelis vaccine (Dtap/Hib/Polio/Hep B) on the same day, 7/24/2023. This resulted in a duplication of the Dtap/HIB/Polio components of the vaccine. Patient's mother was notified. Report child had no ill effects or additional symptoms after vaccination beyond normal fussiness.
Age: 1.25
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered
Clinical narrative: Patient was given an expired dose of ACTHIB on 08/17/23 the expired date was on 08/13/2023,  We have a call out to the patients mother to get a new valid dose given .
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI 2/5/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 70.0
Sex: F
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 10:33 Pediatric Hep A ( Havrix ) was inadvertently given to adult patient. no sign and systems observed on site. no treatment warranted at this time.  Consult with provider and received approval from provider to proceed with administration of Adult Hep A vaccine while patient remain in clinic.
Age: 18.0
Sex: M
Vaccine: MENB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Bexsero vaccine was administered on 20JUL2023 and 2nd Bexsero vaccine was administered on 02AUG2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 18-year-old male patient who received Men B NVS (Bexsero) (expiry date 31-MAR-2024) for prophylaxis.   Concomitant products included MENINGOCOCCAL VACCINE B RFHBP/NADA/NHBA OMV (BEXSERO).   On 02-AUG-2023, the patient received the 2nd dose of Bexsero. On 02-AUG-2023, an unknown time after receiving Bexsero, the patient experienced drug dose administration interval too short (Verbatim: Bexsero vaccine was administered on 20JUL2023 and 2nd Bexsero vaccine was administered on 02AUG2023). The outcome of the drug dose administration interval too short was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 15-Aug-2023 Licensed practical nurse reported that administration of Bexsero 2 weeks apart. The reporter consented to follow-up. The patient received 2nd dose of Bexsero ealier than the recommended interval, which led to shortening of vaccine schedule.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism
Clinical narrative: SADDLE PULMONARY EMBOLISM ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE DVT OF BILAT CALF MUSCULAR VEINS ACUTE PULMONARY EMBOLISM
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, PNC13
Symptoms: Rash, Streptococcus test
Clinical narrative: rash
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid 19 Breakthrough Infection
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE ST ELEVATION MI, INFERIOR WALL ACUTE ST ELEVATION MI, UNSPECIFIED ACUTE MI
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Peripheral swelling, Skin warm, Tenderness
Clinical narrative: Arm swelling, erythema, warmth, tenderness - improved with tylenol.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: OBSTRUCTIVE SLEEP APNEA 5/5/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 9.0
Sex: M
Vaccine: HEP, IPV, MMRV, TDAP
Symptoms: Abdominal pain upper, Headache, Mobility decreased, Muscle spasms, Pyrexia
Clinical narrative: He complained about stomachache after school, but later he complained about headaches, stomachache and had some fever. Also, de felt cramps on his shoulder, legs, hands, fingers, and he complained he couldn't move, and his mom call EMS, for what they said it could had been the vaccine reaction.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arterial disorder, Cerebellar syndrome, Cerebral artery occlusion, Cerebral infarction, Cerebrovascular accident
Clinical narrative: ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY SUPERIOR CEREBELLAR ARTERY SYNDROME
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: NEUROPATHY
Age: 30.0
Sex: M
Vaccine: MNQ
Symptoms: Expired product administered
Clinical narrative: accidentally received an expired dose and Menveo; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 30-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXA701A, expiry date 30-APR-2023) for prophylaxis.   On 15-AUG-2023, the patient received the 1st dose of Menveo. On 15-AUG-2023, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: accidentally received an expired dose and Menveo). The outcome of the expired vaccine used was unknown.   Additional Information: Receipt Date: 16-AUG-2023 The reporter was a pharmacy student. The reporter report that a patient accidentally received an expired dose and Menveo and wished to know how to proceed.  The information about the vaccine and event provided. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up. The patient accidentally received an expired dose and Menveo, which led to expired vaccine used.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 37.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Abnormal sensation in eye, Bell's palsy, Borrelia test, Eyelid ptosis, Full blood count
Clinical narrative: felt ill about 12:30 am the night after immunization, felt heart was pounding. In the morning was very worried, noted left upper eyelid ptosis and an unusual feeling around the eye. Presented to Health Services and heart rate and auscultation were normal, but there was ptosis L and unusual sensation but not numbness from left eye to upper cheek. Referred for immediate eye exam, preliminary diagnosis zoster vs bells palsy, empiric prednisone and valacyclovir prescribed.
Age: 37.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Herpes zoster, Malaise, Metabolic function test, Palpitations
Clinical narrative: felt ill about 12:30 am the night after immunization, felt heart was pounding. In the morning was very worried, noted left upper eyelid ptosis and an unusual feeling around the eye. Presented to Health Services and heart rate and auscultation were normal, but there was ptosis L and unusual sensation but not numbness from left eye to upper cheek. Referred for immediate eye exam, preliminary diagnosis zoster vs bells palsy, empiric prednisone and valacyclovir prescribed.
Age: 21.0
Sex: F
Vaccine: HEP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received pediatric dose of  Engerix B. Should have recieved adult dose. No adverse effects noted. Patient notified of error. awaiting call back from patient to reschedule adult dose.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Recent COVID-19 infection Stable
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Blindness, Hyperhidrosis, Pallor, Syncope, Tinnitus
Clinical narrative: Nursing was called to the hallway for a patient sitting on the floor. Patient was sitting with his head down. Pale, diaphoretic. Mom with patient stated he got a vaccine and he jumped right up he was fine but then when ambulating down hall he had syncopal episode. Mom said he has a phobia of needles and wondering if this may be the cause of the episode or the vaccine. Received his 2nd Meningococcal ACWY vaccine. Mom reported he did eat breakfast. Mom had to help him to the floor. No loss of consciousness reported but Patient reported vision loss and ears ringing. Provided him with juice to drink. HR 68 02 98%. After a few minutes patient reported vision improved and ringing subsided. Was still pale and diaphoretic. Patient was transferred 3 assist to wheelchair and taken to exam room. At 12:08 after entering exam room patient remained seated in wheelchair. BP 82/54 HR 87 O2 100%. Patient had more juice and crackers. Reported he was feeling better. Still had pallor in his face. VS at 12:10 110/72 02 100. % HR 89. Patient mom reported he had to work today and asked if he felt ok if he could work. Patient is a life Guard at pool. Advised may be better to skip work today and rest. Mom stated he had a similar episode in the past with another vaccine HPV mom believed. Advised next time he is to get a vaccine we want him to sit or lay for 15-20 min then stand slowly near exam table for another 2-5 min and insure he is feeling ok. Also offer him snack prior to vaccination. Patient stated he felt ok and would like to attempt work. Advised for his safety and the safety of other let supervisor know and possibly be assigned to office versus life guard duty. Patient rested some more. Stated he felt comfortable leaving and wanted to ambulate under his own power. Had him stand up slowly and stand for a min. Followed him out with the wheelchair at door patient felt fine and mom comfortable escorting him to car.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA
Age: 73.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Fall, Hyperglycaemia, Hypertransaminasaemia, Hypochloraemia
Clinical narrative: Admitted with-injury, DM2 with hyperglycemia, hypochloremia, fall, head transaminitis, non alcoholic fatty liver disease, microcytosis without anemia, overweight, COVID-19 (+)-all present on admission No indication for any immunomodulator antiviral at this time as patient is asymptomatic.  Isolation precautions per protocol
Age: 73.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injury, Microcytosis, Non-alcoholic fatty liver, Overweight, SARS-CoV-2 test positive
Clinical narrative: Admitted with-injury, DM2 with hyperglycemia, hypochloremia, fall, head transaminitis, non alcoholic fatty liver disease, microcytosis without anemia, overweight, COVID-19 (+)-all present on admission No indication for any immunomodulator antiviral at this time as patient is asymptomatic.  Isolation precautions per protocol
Age: 73.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Type 2 diabetes mellitus
Clinical narrative: Admitted with-injury, DM2 with hyperglycemia, hypochloremia, fall, head transaminitis, non alcoholic fatty liver disease, microcytosis without anemia, overweight, COVID-19 (+)-all present on admission No indication for any immunomodulator antiviral at this time as patient is asymptomatic.  Isolation precautions per protocol
Sex: F
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: mother received her first SHINGRIX vaccine sometime in 2019 and has not yet had her 2nd dose.; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 88-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose in 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: mother received her first SHINGRIX vaccine sometime in 2019 and has not yet had her 2nd dose.). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 16-Aug-2023 The patient's son reported that the patient had not yet had her 2nd dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Age: 18.0
Sex: M
Vaccine: HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a third HPV vaccine in error.  No adverse reactions at the time or since that date.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Given after BUD of 10 weeks. No adverse events from patient reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE 1/16/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 92.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Dyspnoea exertional
Clinical narrative: 2/10/2021 010M20A 3/10/2021 048A21A 10/27/2021 FE3590 5/5/2022 FK9894 10/8/2022 GH9702 Pfizer BiValent  6/9/2023 - 6/13/2023 (4 days) Presents hospital progressively worsening generalized weakness for last 1 week and dyspnea on exertion.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: 2/7/2021 031L20A 3/7/2021 031M0A 10/27/2021 939905 5/19/2022 038A22A 9/23/2022 AS7163B Moderna BiValent 6/17/2023 - 6/19/2023 (2 days) Presents to the emergency department for shortness of breath dexamethasone and remdesivir.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fall
Clinical narrative: 6/22/2023 - 7/1/2023 (9 days) presented to the emergency department status post fall at home asx 7/27/2021 EW0161 8/17/2021 EW0173 1/27/2022 33036BD
Sex: U
Vaccine: MNQ
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: a dose that was reconstituted with a sterile solution; a dose that was reconstituted with a sterile solution; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA908A) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: a dose that was reconstituted with a sterile solution) and inappropriate dose of vaccine administered (Verbatim: a dose that was reconstituted with a sterile solution). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: Receipt Date: 16-AUG-2023 The reporter reported that there was a possibility that 1 in 5 patients received a Menveo dose that was reconstituted with a sterile solution and wished to know how to proceed.  The basic information was collected but there was partial information available. The reporter consented to follow up. The patient received a dose that was reconstituted with a sterile solution, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Nausea, Vomiting
Clinical narrative: 6/22/2023 - 6/27/2023 (5 days) presented to the emergency room complain of nausea and vomiting for the last 2 days Regarding COVID-19 infection supportive care only at this point  1/14/2021 013L20A 2/15/2021  031L20A 11/12/2021 939909 4/6/2022 001M21A 10/10/2022 057F22A
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Hyperhidrosis, Pallor, Vomiting
Clinical narrative: Patient received that MCV4-MenQuadfi in Left arm(deltoid). Patient at first tolerated the vaccine. He went to stand and then sat down in the chair. I noticed that his color in his face had changed. He looked pale/pasty. I kept talking with him & told mom to keep talking with him as well. The other two nurses got him a cold compress for his neck & a cold rag for forehead. He was profusely sweating the whole time. He also vomited once in the trash can. We had him sit there until his color got better and he felt better. We had also gave him a bottled water which helped him. He finally said after about 20 minutes that he was feeling better. We advised mom to keep an eye on him that evening & if any changes take him to the ER. Mom voiced understanding. I did call mom that next day to check on him. Mom said that last evening he was tired but did okay. He was doing okay the next day.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: 6/21/2023 - 6/24/2023 (3 days) evaluation of left hip pain post mechanical fall at the ALF patient tested positive on a transfer screen, and then on the same day tested negative on a transfer screen. no treatment was required. EN6198 3/1/2021 ER8727 3/22/2021 33030BD 12/8/2021
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest pain, Diarrhoea, Dyspnoea
Clinical narrative: 6/21/2023 - 6/24/2023 (3 days) presented to the ED with complaints of generalized weakness, worsening shortness of breath upon inspiration over the past few days without fever/chills. Patient did report sharp like, moderate intensity, central chest pain that is radiating to right side chest wall and worse upon deep inspiration.   Patient also reported some diarrhea, nausea and vomiting 1 day prior to ED presentation that self-resolved. 3/9/2021 EN6205  EP7534 3/30/2021  patient had a negative test the same day they had a positive one.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal chest pain, Nausea, Pain, Painful respiration, SARS-CoV-2 test positive
Clinical narrative: 6/21/2023 - 6/24/2023 (3 days) presented to the ED with complaints of generalized weakness, worsening shortness of breath upon inspiration over the past few days without fever/chills. Patient did report sharp like, moderate intensity, central chest pain that is radiating to right side chest wall and worse upon deep inspiration.   Patient also reported some diarrhea, nausea and vomiting 1 day prior to ED presentation that self-resolved. 3/9/2021 EN6205  EP7534 3/30/2021  patient had a negative test the same day they had a positive one.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: 6/21/2023 - 6/24/2023 (3 days) presented to the ED with complaints of generalized weakness, worsening shortness of breath upon inspiration over the past few days without fever/chills. Patient did report sharp like, moderate intensity, central chest pain that is radiating to right side chest wall and worse upon deep inspiration.   Patient also reported some diarrhea, nausea and vomiting 1 day prior to ED presentation that self-resolved. 3/9/2021 EN6205  EP7534 3/30/2021  patient had a negative test the same day they had a positive one.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain
Clinical narrative: 6/25/2023 - 6/28/2023 (3 days) Presents emergency department with abdominal pain. Incidental finding likely and therefore patient was not started on any antiviral medications as she is in asymptomatic.  EL3248 1/22/2021 EN5318 2/12/2021 301258A 11/4/2021 7/9/2022 051B22A
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea
Clinical narrative: 036B21A 4/17/2021 003C21A 5/15/2021 6/26/2023 - 7/1/2023 (5 days) presented to the emergency department complaints of shortness of breath and cough. SHE COMPLETED IV remdesivir, will discharge on Decadron
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Dyspnoea, Pyrexia
Clinical narrative: 038K20A 2/3/2021 031M20A 3/3/2021 058H21A 11/29/2021 past medical history significant for hypertension and hyperlipidemia presented to emergency room complain of fever cough associated shortness of breath   3on oxygen support via nasal cannula started on Decadron IV patient offered  remdesivir but she declined the offer she also treated with ceftriaxone IV as well as azithromycin IV
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: 7/1/2023 - 7/3/2023 (2 days) presented to the emergency room complaining of nausea and vomiting for the last 2 days after being tested positive for COVID-19 treated with supportive care  038K20A 2/3/2021 031M20A 3/3/2021 045J21A 12/7/2021
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia
Clinical narrative: 7/2/2023 - 7/13/2023 (11 days) admitted with Covid 19 pneumonia and acute respiratory failure with  Hypoxia IV Decadron & Remdesivir  EL9263 1/23/2021 EL9267 2/15/2021 30155BA 9/30/2021
Age: 78.0
Sex: M
Vaccine: DTAP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was given DTap shot instead of Tdap shot.  No adverse reaction at this time.